The Oncology Institute’s Post

‼️🎗️‼️REMINDER: Today FDA Oncology Center of Excellence presents its annual “Real Talk: Our Stories as Black Oncologists at the FDA”‼️🎗️‼️ Today, February 27, the FDA Oncology Center of Excellence presents its 6th annual Conversations on Cancer program commemorating Black History Month, “Real Talk: Our Stories as Black Oncologists at the FDA.” This virtual public panel discussion will be held from 1:00 pm to 2:30 pm ET, virtually. Recently, the American Society of Clinical Oncology (ASCO) released data showing that African Americans will likely continue to be under-represented in medical oncology and African Americans compose only 4% of hematology/oncology fellows in the U.S. Trends of graduating physicians from medical schools by race in the U.S. reveal the proportion of racial minorities in the field has increased substantially, except for African Americans. The relatively low number of African American medical oncologists has implications for the oncology workforce and delivery of quality cancer care. Furthermore, the National Academy of Medicine has reported a relationship between a shortage of minority health care providers and poor health outcomes for minority patients. The discussion will feature several African American medical oncologists who work at FDA to discuss their experiences, perspectives, and advice. Register following the link below to receive the YouTube. https://lnkd.in/eSEizhTD #fda #oncology #blackhistorymonth #blackexcellence #blackleaders #cancerawareness #cancercare #cancerresearch #realtalk #blackdoctors #medicaloncology #hematology #minority #asco

🤔 Did you know? 60% of European adults are either unfamiliar with bladder cancer or unaware of its gravity. This lack of awareness can significantly impact early detection and timely intervention. Bladder cancer is a serious health concern, and it's time to break the silence. Together, let’s raise our voices to foster awareness and make a difference in tackling this challenge. Explore our White Paper and learn more about it! 👉 https://ow.ly/UqAA50QiCLr #bladdercancer #bladdercancersupport #whitepaperbladdercancer #fightbladdercancer #bladdercanceradvocacy #bladdercancersupport #bladdercancercare #bladdercanceraware #bladdercancerpolicy #bladdercancereurope European Association of Urology

Did you know that 60% of adults in Europe are either unfamiliar with bladder cancer or unaware of its implications? This shocking statistic from the World Bladder Cancer Patient Coalition is even more poignant when considered against a backdrop of a cancer that is the fifth most common in Europe, with one of the highest lifetime costs of any cancer, and yet with some of the lowest research funding of any cancer. At Combat Medical we’re committed to improving treatment with our BRS hyperthermic system, but raising awareness of bladder cancer and its symptoms is something we can all do. Better awareness helps encourage earlier presentation and can lead to faster diagnosis, and ultimately better patient outcomes. #medicalinnovation #HIVEC #CombatMedical

Did you know that 60% of adults in Europe are either unfamiliar with bladder cancer or unaware of its implications? This shocking statistic from the World Bladder Cancer Patient Coalition is even more poignant when considered against a backdrop of a cancer that is the fifth most common in Europe, with one of the highest lifetime costs of any cancer, and yet with some of the lowest research funding of any cancer. At Combat Medical we’re committed to improving treatment with our BRS hyperthermic system, but raising awareness of bladder cancer and its symptoms is something we can all do. Better awareness helps encourage earlier presentation and can lead to faster diagnosis, and ultimately better patient outcomes. #medicalinnovation #HIVEC #CombatMedical

Did you know that 60% of adults in Europe are either unfamiliar with bladder cancer or unaware of its implications? This shocking statistic from the World Bladder Cancer Patient Coalition is even more poignant when considered against a backdrop of a cancer that is the fifth most common in Europe, with one of the highest lifetime costs of any cancer, and yet with some of the lowest research funding of any cancer. At Combat Medical we’re committed to improving treatment with our BRS hyperthermic system, but raising awareness of bladder cancer and its symptoms is something we can all do. Better awareness helps encourage earlier presentation and can lead to faster diagnosis, and ultimately better patient outcomes. #medicalinnovation #HIVEC #CombatMedical

The future of Thoracic Oncology is in great hands! - Rami Manochakian https://lnkd.in/gFWRdhv3 #oncodaily #oncology #cancer #research #EarlyCareer #Physicians #Researchers

UK Markey Cancer's Dr. Guan-Yu Xiao has secured a $747,000 grant from the National Cancer Institute to study lung cancer metastasis. His work focuses on lung adenocarcinoma, aiming to understand the cellular processes that drive cancer spread. This research could lead to new treatments and tackle resistance to current therapies. Dr. Xiao's findings on the EMT process and the Rab6A protein could revolutionize how we approach cancer treatment. Learn more about this groundbreaking study: https://bit.ly/3S4Nsse #CancerResearch #LungCancer #UKResearch #MedicalInnovation #Healthcare

📈Bladder cancer ranks as Europe’s 5th most common cancer and the 10th worldwide, with over 120,000 EU diagnoses and 52,000 annual deaths. ❗By 2030, projections suggest a rise to 219,000 cases, 40% linked to Europe's aging population. Explore the impactful insights in our White Paper 👉 https://ow.ly/UqAA50QiCLr Let's raise awareness and advocate for improved policies. Together, we can make a difference in the fight against bladder cancer. #bladdercancer #bladdercancersupport #whitepaperbladdercancer #fightbladdercancer #bladdercanceradvocacy #bladdercancersupport #bladdercancercare #bladdercanceraware #bladdercancerpolicy #bladdercancereurope European Association of Urology

Explore this White Paper for impactful insights on Bladder Cancer in Europe 👇

Expert Perspective - Hear from Key Opinion Leaders in Surgical Oncology from around the world: why SCOUT® is the Global Leader in Breast Localization! In Support of Breast Conservation: Learn from Professor Michael Dixon of the University of Edinburgh how they currently use multiple SCOUT reflectors to support and enable oncoplastic breast conservation, and the implications of SCOUT MD™